Amarin Corp PLC (AMRN)
0.8892
+0.02
(+2.68%)
USD |
NASDAQ |
Mar 27, 16:00
0.8751
-0.01
(-1.59%)
Pre-Market: 20:00
Amarin Cash from Financing (TTM): 0.23M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.23M |
September 30, 2023 | 0.185M |
June 30, 2023 | 0.306M |
March 31, 2023 | 0.49M |
December 31, 2022 | -0.379M |
September 30, 2022 | -0.613M |
June 30, 2022 | -0.567M |
March 31, 2022 | -0.385M |
December 31, 2021 | -5.073M |
September 30, 2021 | -10.48M |
June 30, 2021 | -23.66M |
March 31, 2021 | -38.24M |
December 31, 2020 | -58.91M |
September 30, 2020 | -72.62M |
June 30, 2020 | 374.08M |
March 31, 2020 | 383.80M |
December 31, 2019 | 409.61M |
September 30, 2019 | 629.47M |
June 30, 2019 | 203.92M |
March 31, 2019 | 205.99M |
December 31, 2018 | 271.25M |
September 30, 2018 | 67.40M |
June 30, 2018 | 59.45M |
March 31, 2018 | 61.70M |
December 31, 2017 | 8.235M |
Date | Value |
---|---|
September 30, 2017 | 11.54M |
June 30, 2017 | 75.44M |
March 31, 2017 | 75.55M |
December 31, 2016 | 63.13M |
September 30, 2016 | 74.34M |
June 30, 2016 | 16.03M |
March 31, 2016 | 16.50M |
December 31, 2015 | 71.47M |
September 30, 2015 | 60.28M |
June 30, 2015 | 59.58M |
March 31, 2015 | 56.67M |
December 31, 2014 | 2.633M |
September 30, 2014 | 1.316M |
June 30, 2014 | 117.83M |
March 31, 2014 | 120.69M |
December 31, 2013 | 121.62M |
September 30, 2013 | 224.44M |
June 30, 2013 | 108.04M |
March 31, 2013 | 134.42M |
December 31, 2012 | 280.28M |
September 30, 2012 | 181.45M |
June 30, 2012 | 180.91M |
March 31, 2012 | 166.85M |
December 31, 2011 | 126.65M |
September 30, 2011 | 133.45M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-72.62M
Minimum
Sep 2020
629.47M
Maximum
Sep 2019
99.86M
Average
-0.097M
Median
Cash from Financing (TTM) Benchmarks
Trinity Biotech PLC | -15.68M |
DBV Technologies SA | 6.767M |
Biodexa Pharmaceuticals Plc | 7.972M |
Verona Pharma PLC | 92.87M |
Evaxion Biotech AS | -- |